These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19458204)

  • 1. Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.
    Johnson BW; Kosoy O; Hunsperger E; Beltran M; Delorey M; Guirakhoo F; Monath T
    Clin Vaccine Immunol; 2009 Jul; 16(7):1052-9. PubMed ID: 19458204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavivirus-induced antibody cross-reactivity.
    Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR
    J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the protective ability of plasma from Japanese individuals against mosquito-borne viral infections.
    Shinohara N; Owada T; Matsumoto C; Uchida S; Nagai T; Satake M; Tadokoro K
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):393-401. PubMed ID: 29294131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cross-reactivity among flaviviruses using sera of patients with dengue showed the importance of neutralization tests with paired serum samples for the correct interpretations of serological test results for dengue.
    Maeki T; Tajima S; Ando N; Wakimoto Y; Hayakawa K; Kutsuna S; Kato F; Taniguchi S; Nakayama E; Lim CK; Saijo M
    J Infect Chemother; 2023 May; 29(5):469-474. PubMed ID: 36702208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of widely used diagnostic tests to detect West Nile virus infections in horses previously infected with St. Louis encephalitis virus or dengue virus type 2.
    Ledermann JP; Lorono-Pino MA; Ellis C; Saxton-Shaw KD; Blitvich BJ; Beaty BJ; Bowen RA; Powers AM
    Clin Vaccine Immunol; 2011 Apr; 18(4):580-7. PubMed ID: 21346058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test.
    Lee HJ; Min KI; Park KH; Choi HJ; Kim MK; Ahn CY; Hong YJ; Kim YB
    J Microbiol; 2014 May; 52(5):435-40. PubMed ID: 24610332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of plaque reduction and focus reduction neutralization tests for the measurement of neutralizing antibody titers against japanese encephalitis virus.
    Park Y; Kim AR; Hwang YH; Yang H; Lee JW; Kim MY; Kim HS; Chung GT; Yoo JS; Kim YJ; Kim D; Won H
    J Virol Methods; 2022 Aug; 306():114540. PubMed ID: 35550887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
    Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.
    Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2008; 52(4):219-24. PubMed ID: 19143477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.
    Rainwater-Lovett K; Rodriguez-Barraquer I; Cummings DA; Lessler J
    BMC Infect Dis; 2012 Sep; 12():233. PubMed ID: 23020074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses.
    Pushpakumara PD; Jeewandara C; Gomes L; Perera Y; Wijewickrama A; Malavige GN; Goonesekara C
    PLoS One; 2020; 15(10):e0238609. PubMed ID: 33112881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a virus-specific continuous B-cell epitope on the PrM/M protein of Japanese Encephalitis Virus: potential application in the detection of antibodies to distinguish Japanese Encephalitis Virus infection from West Nile Virus and Dengue Virus infections.
    Hua RH; Chen NS; Qin CF; Deng YQ; Ge JY; Wang XJ; Qiao ZJ; Chen WY; Wen ZY; Liu WX; Hu S; Bu ZG
    Virol J; 2010 Sep; 7():249. PubMed ID: 20858291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonstructural protein 1 antibody-based epitope-blocking enzyme-linked immunosorbent assay to differentiate Japanese encephalitis virus from dengue virus infections in humans.
    Konishi E; Konishi M
    Jpn J Infect Dis; 2011; 64(4):284-91. PubMed ID: 21788702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity of chicken anti-Japanese encephalitis virus serum and anti-West Nile virus serum in serological diagnosis.
    Hirota J; Shimizu S; Shibahara T; Kobayashi S
    J Vet Med Sci; 2012 Nov; 74(11):1497-9. PubMed ID: 22785078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans.
    Galula JU; Chang GJ; Chuang ST; Chao DY
    J Clin Microbiol; 2016 Feb; 54(2):412-22. PubMed ID: 26659204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
    Johnson BW; Kosoy O; Martin DA; Noga AJ; Russell BJ; Johnson AA; Petersen LR
    Vector Borne Zoonotic Dis; 2005; 5(2):137-45. PubMed ID: 16011430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.